List view / Grid view
15 October 2015 | By Victoria White
In a study, examining the activity of only five genes in a sample of the tumour was enough to identify high-risk children who might benefit from more intensive treatment...
15 October 2015 | By Victoria White
Under the terms of the agreement, Hikma will have the exclusive rights to register, distribute and market Zevtera in all its Middle Eastern and North African markets...
15 October 2015 | By Victoria White
Valeant has also revealed that it has responded to a letter from US Senator Claire McCaskill concerning the price of Nitropress and Isuprel...
15 October 2015 | By Victoria White
As well as an upfront payment of $350 million, Five Prime will be eligible to receive up to $1.05 billion in development and regulatory milestone payments...
15 October 2015 | By Victoria White
CPhI highlights these risks in the fourth and final section of its 2015 annual report, The Outsourcing perspective...
14 October 2015 | By Victoria White
Janssen’s EPIDEPSO study was initiated to better understand the correlation between psychosocial comorbidities and psoriasis...
14 October 2015 | By BioTek
BioTek is excited to introduce the new Cytation™ 5 Cell Imaging Multi-Mode Reader...
14 October 2015 | By Victoria White
Verona Pharma has announced that the first patients have been dosed in a Phase IIa combination study to evaluate the addition of RPL554 to standard reliever medications for COPD...
Lilly and Incyte have announced positive topline results from the fourth successful Phase 3 study (RA-BEAM ) of baricitinib.
14 October 2015 | By BioTek
BioTek introduces Synergy Neo2 high performance Multi-Mode Microplate Reader...
14 October 2015 | By Victoria White
Merck says that the fundamental revision of the visual appearance as well as the introduction of a new logo reflect its transformation into a global science and technology company...
14 October 2015 | By Victoria White
The review indicates that the near-term growth prospects are highest across generics, small molecule injectables, and in contract services...
13 October 2015 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, will be highlighting the benefits of its unique, integrated approach to formulation development, real-time adaptive manufacturing and clinical testing on booth 1662...
13 October 2015 | By Victoria White
Preclinical evidence suggests that the combination of these two agents may lead to an enhanced anti-tumour immune response...
13 October 2015 | By Victoria White
CPI and Arecor carried out the investigation with the hope of improving stability and shelf life throughout transportation and storage...
